Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A cannabinoid type 2 (CB2) receptor agonist augments NOS-dependent responses of cerebral arterioles during type 1 diabetes

Microvascular Research(2020)10.1016/j.mvr.2020.104077Source: DataRank Database

A cannabinoid type 2 (CB2) receptor agonist augments NOS-dependent responses of cerebral arterioles during type 1 diabetes is a research paper published in Microvascular Research (2020). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.58)OA: greenTopics (38)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Kirsten R. Kim,Denise M. Arrick,William G. Mayhan ORCID,Lauren Van Hove

Live enrichment

PubMed:32979391 PMC:PMC7704564 OpenAlex:https://openalex.org/W3089307779

NIAAA NIH HHS

Grant: R01 AA027206

NHLBI NIH HHS

Grant: R01 HL079587

NIH

Grant: AA027206

University of South Dakota

FWCI

0.58

Citation Percentile

0.7%

Citation Trend

2021

2022

2023

2024

2025

greenLicense: https://www.elsevier.com/legal/tdmrep-license

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7704564

publisherhttps://api.elsevier.com/content/article/PII:S0026286220301370?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0026286220301370?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.mvr.2020.104077

Fields of Study

Cannabis and Cannabinoid ResearchPrenatal Substance Exposure EffectsAlcohol Consumption and Health Effects

MeSH Terms

AnimalsArteriolesBrainCannabinoidsCerebrovascular DisordersDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 1MaleVasodilationVasodilator AgentsSignal TransductionRats, Sprague-DawleyReceptor, Cannabinoid, CB2RatsNitric Oxide Synthase Type INitric Oxide Synthase Type IIICannabinoid Receptor Agonists

Keywords

AgonistInternal medicineEndocrinologyNeuroprotectionCannabinoidCannabinoid receptorCannabinoid receptor type 2MedicineReceptorEnosPharmacologyNitric oxide synthaseNitric oxideBrainADPNMDAreactivityJwh-133

Sustainable Development Goals

SDG 0: Good health and well-being

A cannabinoid type 2 (CB2) receptor agonist augments NOS-dependent responses of cerebral arterioles during type 1 diabetes

FAIR Checklist

Authors (4)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)